Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. PNTG
PNTG logo

PNTG Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Pennant Group Inc (PNTG) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Buy
Latest Price
29.300
1 Day change
1.38%
52 Week Range
35.000
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Pennant Group Inc (PNTG) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company's strong financial performance, bullish analyst ratings, and favorable technical indicators support this decision. While there are no immediate trading signals or significant news catalysts, the company's growth trends and sector positioning make it an attractive long-term investment.

Technical Analysis

The stock shows bullish moving averages (SMA_5 > SMA_20 > SMA_200), with the MACD histogram above 0, indicating positive momentum. RSI is neutral at 42.82, and the stock is trading near its pivot level of 30.607. Support and resistance levels are well-defined, with key support at 29.706 and resistance at 31.509.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
7
Buy
6

Positive Catalysts

  • Strong financial performance in Q4 2025, with revenue up 53.17% YoY and net income up 50.00% YoY.

  • Analysts have raised price targets, with Truist setting it at $36 and RBC Capital at $41, reflecting confidence in the company's growth potential.

  • Favorable sector trends, including strong demand, AI/automation benefits, and a stable reimbursement backdrop.

Neutral/Negative Catalysts

  • No recent news or significant trading trends from hedge funds or insiders.

  • Lack of immediate trading signals from AI Stock Picker or SwingMax.

  • Short-term stock trend analysis indicates a potential -2.29% decline over the next week.

Financial Performance

In Q4 2025, Pennant Group reported a revenue increase of 53.17% YoY to $289.32M, net income growth of 50.00% YoY to $8.64M, and EPS growth of 50.00% YoY to 0.24. Gross margin improved to 12.59%, up 7.06% YoY, indicating strong operational performance.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts remain bullish on Pennant Group. Truist raised its price target to $36, citing strong demand trends and favorable sector conditions, while RBC Capital increased its target to $41, highlighting confidence in the company's long-term earnings potential.

Wall Street analysts forecast PNTG stock price to rise
6 Analyst Rating
Wall Street analysts forecast PNTG stock price to rise
6 Buy
0 Hold
0 Sell
Strong Buy
Current: 28.900
sliders
Low
34
Averages
37.6
High
40
Current: 28.900
sliders
Low
34
Averages
37.6
High
40
Truist
David MacDonald
Buy
maintain
$34 -> $36
AI Analysis
2026-04-13
Reason
Truist
David MacDonald
Price Target
$34 -> $36
AI Analysis
2026-04-13
maintain
Buy
Reason
Truist analyst David MacDonald raised the firm's price target on Pennant Group to $36 from $34 and keeps a Buy rating on the shares as part of a broader research note previewing Q1 results in Healthcare Services, or HC. The firm remains broadly bullish on its HC Services coverage universe tied to continued strong demand trends, overarching secular tailwinds and more favorable/stable reimbursement backdrop, with the recent Final Medicare Advantage Rule seen as an "encouraging data point", the analyst tells investors in a research note. Truist adds that it continues to think the sector is well positioned given that it's scaled, domestic and defensive, also noting that the group is a beneficiary of AI/automation/interconnectivity, with strong free cash flow and attractive financial flexibility supporting the ongoing growth investment/M&A/shareholder friendly initiatives.
RBC Capital
Outperform
maintain
$39 -> $41
2026-03-02
Reason
RBC Capital
Price Target
$39 -> $41
2026-03-02
maintain
Outperform
Reason
RBC Capital raised the firm's price target on Pennant Group to $41 from $39 and keeps an Outperform rating on the shares. The company's 2026 adjusted EBITDA guidance came in below expectations, but the firm remains confident in the long-term earnings potential of AMED assets, which Pennant should be able to unlock over time, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for PNTG
Unlock Now

People Also Watch